RESEARCH & DEVELOPMENT
NANO-BASED DRUG DELIVERY Road towards cancer therapy management Cancer is a leading cause of death globally. Despite therapeutic advancement, the rate of cancer mortality has increased in past few years. The major drawback of anti-cancer drugs is non-specific delivery, which causes adverse side-effects and toxicity. Nano-based drug delivery systems could help us minimise adverse sideeffects and in better cancer therapy management. Dhruv Kumar, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University 26
P H A RM A F O C U S A S I A
ISSUE 38 - 2020
I
n the past few decades, nanotechnology has emerged as one of the most important approaches for cancer diagnosis and therapeutics. More recently, nanoparticle (NP) based specific drug delivery approaches have gained attention of researchers and clinicians to take one step towards specific tissue/organ specific drug delivery against cancer. NPs display an adaptable role in disease/cancer diagnosis and treatment and showed several
